46 related articles for article (PubMed ID: 18347611)
1. The Interaction of Apolipoprotein E and Angiotensin I-Converting Enzyme Dna Polymorphisms with Hypertension on Early Ischemic Stroke Risk.
Stankovic S; Stankovic A; Asanin M; Jovanovic-Markovic Z; Alavantic D; Majkic-Singh N
EJIFCC; 2010 Mar; 21(1):13-8. PubMed ID: 27683351
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics in Cardiovascular Diseases.
McDonough CW
Curr Protoc; 2021 Jul; 1(7):e189. PubMed ID: 34232575
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Angiotensin II Type 1 Receptor Antibodies in Persons With Hypertension and Relation to Blood Pressure and Medication.
Philogene MC; Han D; Alvarado F; Fedarko NS; Zonderman AB; Evans MK; Crews DC
Am J Hypertens; 2020 Aug; 33(8):734-740. PubMed ID: 32330222
[TBL] [Abstract][Full Text] [Related]
4. Hypertension pharmacogenomics: in search of personalized treatment approaches.
Cooper-DeHoff RM; Johnson JA
Nat Rev Nephrol; 2016 Feb; 12(2):110-22. PubMed ID: 26592190
[TBL] [Abstract][Full Text] [Related]
5. Gene-drug interaction in stroke.
Amici S; Paciaroni M; Agnelli G; Caso V
Stroke Res Treat; 2011; 2011():212485. PubMed ID: 22135769
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance.
Arnett DK; Claas SA
Pharmacogenomics; 2009 Aug; 10(8):1295-307. PubMed ID: 19663674
[TBL] [Abstract][Full Text] [Related]
7. Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension?
Arnett DK; Claas SA; Lynch AI
Curr Opin Cardiol; 2009 Jul; 24(4):333-9. PubMed ID: 19509486
[TBL] [Abstract][Full Text] [Related]
8. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
Cohn JN
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):137-9. PubMed ID: 14608516
[TBL] [Abstract][Full Text] [Related]
9. [Hypertension 2007-2008].
Chatzikyrkou C; Menne J; Haller H
Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
[TBL] [Abstract][Full Text] [Related]
10. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH
Pharmacogenomics J; 2008 Dec; 8(6):400-7. PubMed ID: 18347611
[TBL] [Abstract][Full Text] [Related]
11. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the renin--angiotensin system, use of renin--angiotensin system inhibitors and the risk of myocardial infarction.
Maitland-van der Zee AH; van Wieren-de Wijer DB; de Boer A; Kroon AA; de Leeuw PW; Schiffers P; Janssen RG; Psaty BM; van Duijn CM; Stricker BH; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):208-14. PubMed ID: 21163865
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Br J Clin Pharmacol; 2007 Jul; 64(1):57-66. PubMed ID: 17298481
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
